two new biotech drugs for colorectal cancer

March 2004

You'll see two new biotech drugs for colorectal cancer, Avastin and Erbitux.

Avastin (bevacizumab) is the first angiogenesis inhibitor approved by the FDA. It works by slowing the growth of new blood vessels that tumors need to grow.

It's approved for metastatic colorectal cancer...in combination with traditional chemotherapy.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Counterfeit drugs are now a much bigger problem
best approach for treating patients with signs of worsening asthma
Less than HALF of the people carrying epinephrine auto-injectors know when or how to use them properly
Zicam (zinc nasal gel) causes loss of smell
potential interaction between warfarin and glucosamine-chondroitin supplements (Cosamin DS, etc)
new guidelines for monitoring patients on atypical antipsychotics
watch for metabolic acidosis in patients taking Topamax (topiramate)
Infectious Diseases best time to give varicella vaccine
Infectious Diseases Bird flu is causing quite a flap
Hematology & Oncology whether antibiotics increase the risk of breast cancer
Hematology & Oncology two new biotech drugs for colorectal cancer
Dermatology antifungal cream will soon hit the market called Ertaczo (er-TACS-oh)
Ophthalmology what to use for allergic conjunctivitis
Osteoporosis strontium for bone loss
Women's Health heart disease should be treated in WOMEN just as aggressively as it's treated in MEN

two new biotech drugs for colorectal cancer

Practical advice for a better career, with unlimited access to CE

Table of Contents